A Direct Role for the CD1b Endogenous Spacer in the Recognition of a Mycobacterium tuberculosis Antigen by T-Cell Receptors

Lipids, glycolipids and lipopeptides derived from Mycobacterium tuberculosis (Mtb) are presented to T cells by monomorphic molecules known as CD1. This is the case of the Mtb-specific sulfoglycolipid Ac2SGL, which is presented by CD1b molecules and is recognized by T cells found in tuberculosis (TB)...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2020
Institución:
Universidad de Medellín
Repositorio:
Repositorio UDEM
Idioma:
eng
OAI Identifier:
oai:repository.udem.edu.co:11407/5906
Acceso en línea:
http://hdl.handle.net/11407/5906
Palabra clave:
Ac2SGL
CD1b
endogenous spacer
Mycobacterium tuberculosis
scTCR
sulfoglycolipids
amino acid
CD1b antigen
glucose
glucose monomycolate
Mycobacterium antigen
sulfuric acid
T lymphocyte receptor
unclassified drug
Article
crystal structure
enzyme linked immunosorbent assay
human
hypothesis
light chain
molecular docking
Mycobacterium tuberculosis
protein lipid interaction
protein structure
T lymphocyte
tuberculosis
Rights
License
http://purl.org/coar/access_right/c_16ec
Description
Summary:Lipids, glycolipids and lipopeptides derived from Mycobacterium tuberculosis (Mtb) are presented to T cells by monomorphic molecules known as CD1. This is the case of the Mtb-specific sulfoglycolipid Ac2SGL, which is presented by CD1b molecules and is recognized by T cells found in tuberculosis (TB) patients and in individuals with latent infections. Our group, using filamentous phage display technology, obtained two specific ligands against the CD1b-Ac2SGL complex: (i) a single chain T cell receptor (scTCR) from a human T cell clone recognizing the CD1b-AcSGL complex; and (ii) a light chain domain antibody (dAbκ11). Both ligands showed lower reactivity to a synthetic analog of Ac2SGL (SGL12), having a shorter acyl chain as compared to the natural antigen. Here we put forward the hypothesis that the CD1b endogenous spacer lipid (EnSpacer) plays an important role in the recognition of the CD1b-Ac2SGL complex by specific T cells. To support this hypothesis we combined: (a) molecular binding assays for both the scTCR and the dAbκ11 antibody domain against a small panel of synthetic Ac2SGL analogs having different acyl chains, (b) molecular modeling of the CD1b-Ac2SGL/EnSpacer complex, and (c) modeling of the interactions of this complex with the scTCR. Our results contribute to understand the mechanisms of lipid presentation by CD1b molecules and their interactions with T-cell receptors and other specific ligands, which may help to develop specific tools targeting Mtb infected cells for therapeutic and diagnostic applications. © Copyright © 2020 Camacho, Moreno, Garcia-Alles, Chinea Santiago, Gilleron, Vasquez, Choong, Reyes, Norazmi, Sarmiento and Acosta.